Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Zai Lab Ltd | Director | American Depositary Shares | 49.1K | $1.05M | $21.33 | Jun 18, 2024 | Direct |
Alkermes plc. | Director | Ordinary Shares | 25K | $602K | $24.10 | Jun 29, 2024 | Direct |
Alkermes plc. | Director | Non Qualified Stock Option (Right to Buy) | 17.5K | $537K | $30.72 | May 31, 2024 | Direct |
INFINITY PHARMACEUTICALS, INC. | Director | Stock Option(right to buy) | 45K | Jun 16, 2022 | Direct | ||
Alkermes plc. | Director | Restricted Stock Unit Award | 0 | Jun 29, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
ALKS | Alkermes plc. | Jun 29, 2024 | 3 | -$35.3K | 4 | Jul 1, 2024 | Director |
ZLAB | Zai Lab Ltd | Jun 18, 2024 | 1 | $0 | 4 | Jun 20, 2024 | Director |
ALKS | Alkermes plc. | May 31, 2024 | 10 | $61.4K | 4 | Jun 4, 2024 | Director |
ALKS | Alkermes plc. | Jul 7, 2023 | 3 | -$42.7K | 4 | Jul 10, 2023 | Director |
ALKS | Alkermes plc. | Jun 29, 2023 | 2 | $0 | 4 | Jun 30, 2023 | Director |
ZLAB | Zai Lab Ltd | Jun 29, 2023 | 1 | $500K | 4 | Jun 30, 2023 | Director |
ALKS | Alkermes plc. | Jul 7, 2022 | 2 | $0 | 4 | Jul 8, 2022 | Director |
INFI | INFINITY PHARMACEUTICALS, INC. | Jun 16, 2022 | 1 | $0 | 4 | Jun 16, 2022 | Director |
ALKS | Alkermes plc. | Jun 14, 2022 | 3 | -$18.9K | 4 | Jun 16, 2022 | Director |
ALKS | Alkermes plc. | Dec 2, 2021 | 3 | -$29.6K | 4 | Dec 3, 2021 | Director |
ZLAB | Zai Lab Ltd | Nov 19, 2021 | 1 | $0 | 4 | Nov 22, 2021 | Director |
ZLAB | Zai Lab Ltd | Nov 19, 2021 | 0 | $0 | 3 | Nov 22, 2021 | Director |
ALKS | Alkermes plc. | Jun 14, 2021 | 2 | $0 | 4 | Jun 16, 2021 | Director |
INFI | INFINITY PHARMACEUTICALS, INC. | Jun 10, 2021 | 1 | $0 | 4 | Jun 11, 2021 | Director |
ALKS | Alkermes plc. | May 20, 2021 | 3 | -$30.8K | 4 | May 21, 2021 | Director |